Literature DB >> 17028879

The Strata programmable valve for shunt-dependent hydrocephalus: the pediatric experience at a single institution.

Edward S Ahn1, Markus Bookland, Benjamin S Carson, Jon D Weingart, George I Jallo.   

Abstract

BACKGROUND AND
OBJECTIVE: The Medtronic PS Medical Strata valve has pressure flow characteristics that are noninvasively adjusted with a magnetic tool. The objective of this study was to examine its efficacy during our initial experience with it in shunt-dependent children.
MATERIALS AND METHODS: A retrospective review of 53 children with a median age of 2.0 years who had 61 Strata valves implanted.
CONCLUSION: The Strata valve is efficacious in the treatment of shunt-dependant hydrocephalus in children. The 1-year shunt survival rate of 67.2% is comparable to that previously reported from a multicenter trial. Of the 30 therapeutically aimed adjustments during the study period, 16 (53.3%) resulted in improvement in abnormal signs or symptoms. Our data indicate that adjustments can be used to treat signs or symptoms of cerebrospinal fluid overdrainage or underdrainage, which may obviate the need for additional surgery.

Entities:  

Mesh:

Year:  2006        PMID: 17028879     DOI: 10.1007/s00381-006-0236-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  25 in total

1.  Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective study of 583 patients.

Authors:  G Zemack; B Romner
Journal:  J Neurosurg       Date:  2000-06       Impact factor: 5.115

2.  A multicenter prospective cohort study of the Strata valve for the management of hydrocephalus in pediatric patients.

Authors:  John R W Kestle; Marion L Walker
Journal:  J Neurosurg       Date:  2005-03       Impact factor: 5.115

3.  Postshunt insertion CSF leaks in infants treated by an adjustable valve opening pressure reduction.

Authors:  Veit Rohde; Martin Weinzierl; Lothar Mayfrank; Joachim M Gilsbach
Journal:  Childs Nerv Syst       Date:  2002-08-24       Impact factor: 1.475

4.  Adjustment and malfunction of a programmable valve after exposure to toy magnets. Case report.

Authors:  Richard C E Anderson; Marion L Walker; John M Viner; John R W Kestle
Journal:  J Neurosurg       Date:  2004-11       Impact factor: 5.115

5.  Clinical experience with a new pressure-adjustable shunt valve.

Authors:  A Reinprecht; T Czech; W Dietrich
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  The Medos Hakim programmable valve in the treatment of pediatric hydrocephalus.

Authors:  A Reinprecht; W Dietrich; A Bertalanffy; T Czech
Journal:  Childs Nerv Syst       Date:  1997 Nov-Dec       Impact factor: 1.475

7.  Does age or other factors influence the incidence of ventriculoperitoneal shunt infections?

Authors:  S E Davis; M L Levy; J G McComb; L Masri-Lavine
Journal:  Pediatr Neurosurg       Date:  1999-05       Impact factor: 1.162

8.  Overdrainage phenomena in shunt treated hydrocephalus.

Authors:  K Faulhauer; P Schmitz
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

9.  The incidence and management of the slit ventricle syndrome.

Authors:  W Serlo; A L Saukkonen; E Heikkinen; L von Wendt
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

10.  Slit-ventricle syndrome: review of 15 cases.

Authors:  R L McLaurin; A Olivi
Journal:  Pediatr Neurosci       Date:  1987
View more
  10 in total

1.  Valve exchange towards an adjustable differential pressure valve with gravitational unit, clinical outcome of a single-center study.

Authors:  S Alavi; M Schulz; A Schaumann; K Schwarz; Ulrich W Thomale
Journal:  Childs Nerv Syst       Date:  2017-03-22       Impact factor: 1.475

Review 2.  Is there an ideal shunt? A panoramic view of 110 years in CSF diversions and shunt systems used for the treatment of hydrocephalus: from historical events to current trends.

Authors:  Nigel Peter Symss; Shizuo Oi
Journal:  Childs Nerv Syst       Date:  2014-12-30       Impact factor: 1.475

Review 3.  Antisiphon device: A review of existing mechanisms and clinical applications to prevent overdrainage in shunted hydrocephalic patients.

Authors:  An-Ping Huang; Lu-Ting Kuo; Dar-Ming Lai; Shih-Hung Yang; Meng-Fai Kuo
Journal:  Biomed J       Date:  2021-08-17       Impact factor: 7.892

4.  Adjustments in gravitational valves for the treatment of childhood hydrocephalus-a retrospective survey.

Authors:  Anna Felicitas Gebert; Matthias Schulz; Hannes Haberl; Ulrich-Wilhelm Thomale
Journal:  Childs Nerv Syst       Date:  2013-05-29       Impact factor: 1.475

5.  Management of neonatal hydrocephalus: feasibility of use and safety of two programmable (Sophy and Polaris) valves.

Authors:  Juan F Martínez-Lage; María-José Almagro; Isabel Sanchez Del Rincón; Miguel A Pérez-Espejo; Claudio Piqueras; Raúl Alfaro; Javier Ros de San Pedro
Journal:  Childs Nerv Syst       Date:  2007-10-09       Impact factor: 1.475

6.  Shunt technology for infants and a lifetime.

Authors:  Víctor J Fernández Cornejo; Samer K Elbabaa
Journal:  Childs Nerv Syst       Date:  2021-07-08       Impact factor: 1.475

7.  Maladjustment of programmable ventricular shunt valves by inadvertent exposure to a common hospital device.

Authors:  R Fujimura; R Lober; K Kamian; L Kleiner
Journal:  Surg Neurol Int       Date:  2018-03-01

Review 8.  Infant hydrocephalus: what valve first?

Authors:  Benjamin J Hall; Conor S Gillespie; Geraint J Sunderland; Elizabeth J Conroy; Dawn Hennigan; Michael D Jenkinson; Benedetta Pettorini; Conor Mallucci
Journal:  Childs Nerv Syst       Date:  2021-08-17       Impact factor: 1.475

9.  Retrospective single-center historical comparative study between proGAV and proGAV2.0 for surgical revision and implant duration.

Authors:  E Brunner; A Schaumann; V Pennacchietti; M Schulz; U W Thomale
Journal:  Childs Nerv Syst       Date:  2022-03-30       Impact factor: 1.532

Review 10.  A Review of Cerebral Shunts, Current Technologies, and Future Endeavors.

Authors:  Garrett J Soler; Mengdi Bao; Devina Jaiswal; Hitten P Zaveri; Michael L DiLuna; Ryan A Grant; Kazunori Hoshino
Journal:  Yale J Biol Med       Date:  2018-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.